The RSI Indicator for SNZZF moved out of oversold territory on December 12, 2024. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 12 similar instances when the indicator left oversold territory. In of the 12 cases the stock moved higher. This puts the odds of a move higher at .
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 21 cases where SNZZF's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on December 18, 2024. You may want to consider a long position or call options on SNZZF as a result. In of 20 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for SNZZF just turned positive on December 16, 2024. Looking at past instances where SNZZF's MACD turned positive, the stock continued to rise in of 17 cases over the following month. The odds of a continued upward trend are .
SNZZF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
SNZZF moved below its 50-day moving average on December 04, 2024 date and that indicates a change from an upward trend to a downward trend.
The Aroon Indicator for SNZZF entered a downward trend on December 17, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.237) is normal, around the industry mean (23.300). P/E Ratio (0.000) is within average values for comparable stocks, (83.485). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (16.155) is also within normal values, averaging (43.338).
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. SNZZF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SNZZF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.
Industry MedicalSpecialties
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
VGLT | 56.43 | -0.67 | -1.17% |
Vanguard Long-Term Treasury ETF | |||
DIVI | 30.18 | -0.75 | -2.42% |
Franklin Intl Core Div Tlt Idx ETF | |||
TDV | 75.77 | -2.11 | -2.71% |
ProShares S&PTech Div Arstcrts ETF | |||
BBP | 59.76 | -2.56 | -4.11% |
Virtus LifeSci Biotech Products ETF | |||
EDC | 29.23 | -2.19 | -6.97% |
Direxion Daily MSCI Em Mkts Bull 3X ETF |
A.I.dvisor tells us that SNZZF and COO have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SNZZF and COO's prices will move in lockstep.
Ticker / NAME | Correlation To SNZZF | 1D Price Change % | ||
---|---|---|---|---|
SNZZF | 100% | N/A | ||
COO - SNZZF | 22% Poorly correlated | -2.22% | ||
MYO - SNZZF | 22% Poorly correlated | -6.17% | ||
COCH - SNZZF | 21% Poorly correlated | -10.00% | ||
RDNT - SNZZF | 21% Poorly correlated | -5.37% | ||
SSMXY - SNZZF | 10% Poorly correlated | -2.34% | ||
More |